Scarica l'app Stockscreener
21.09
6.39%
-1.44
Dopo l'orario di chiusura:
21.09
Precedente Chiudi:
$22.53
Aprire:
$22.51
Volume 24 ore:
537.18K
Relative Volume:
1.01
Capitalizzazione di mercato:
$590.46M
Reddito:
$17.16M
Utile/perdita netta:
$-163.62M
Rapporto P/E:
-3.4688
EPS:
-6.08
Flusso di cassa netto:
$-121.61M
1 W Prestazione:
+4.77%
1M Prestazione:
-12.96%
6M Prestazione:
+38.30%
1 anno Prestazione:
-43.20%
Intervallo 1D:
$20.82
$22.98
Intervallo di 1 settimana:
$19.86
$22.98
Portata 52W:
$12.21
$40.70
Anaptysbio Inc Stock (ANAB) Company Profile
Nome
Anaptysbio Inc
Settore
Industria
Telefono
858-362-6295
Indirizzo
10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA
Confronta ANAB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ANAB
Anaptysbio Inc
|
21.09 | 576.52M | 17.16M | -163.62M | -121.61M | -6.08 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Anaptysbio Inc Stock (ANAB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-04 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2025-02-04 | Iniziato | Wolfe Research | Outperform |
| 2024-12-11 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2024-12-02 | Downgrade | BTIG Research | Buy → Neutral |
| 2024-07-22 | Iniziato | H.C. Wainwright | Buy |
| 2024-07-19 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2024-04-16 | Iniziato | Leerink Partners | Outperform |
| 2024-04-11 | Iniziato | Wells Fargo | Overweight |
| 2024-03-12 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2024-02-26 | Iniziato | BTIG Research | Buy |
| 2024-02-21 | Iniziato | Stifel | Buy |
| 2024-02-16 | Iniziato | Piper Sandler | Overweight |
| 2023-05-22 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2023-05-18 | Iniziato | TD Cowen | Outperform |
| 2023-01-06 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2022-11-01 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2022-09-19 | Ripresa | H.C. Wainwright | Buy |
| 2022-09-13 | Downgrade | Truist | Buy → Hold |
| 2022-09-01 | Iniziato | Raymond James | Outperform |
| 2022-03-22 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-06-22 | Iniziato | H.C. Wainwright | Buy |
| 2021-05-21 | Iniziato | UBS | Neutral |
| 2021-03-16 | Aggiornamento | Truist | Hold → Buy |
| 2021-03-09 | Downgrade | Wedbush | Outperform → Neutral |
| 2021-03-08 | Downgrade | JP Morgan | Overweight → Underweight |
| 2021-02-11 | Aggiornamento | JP Morgan | Underweight → Overweight |
| 2020-10-27 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2020-10-14 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2019-11-08 | Downgrade | JP Morgan | Overweight → Underweight |
| 2019-11-08 | Downgrade | Jefferies | Buy → Hold |
| 2019-11-08 | Downgrade | SunTrust | Buy → Hold |
| 2019-11-08 | Downgrade | Wedbush | Outperform → Neutral |
| 2019-06-21 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2019-06-21 | Downgrade | Stifel | Buy → Hold |
| 2018-12-20 | Iniziato | H.C. Wainwright | Buy |
| 2018-11-21 | Iniziato | JP Morgan | Overweight |
| 2018-07-19 | Iniziato | Credit Suisse | Outperform |
| 2018-04-04 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2018-03-27 | Reiterato | Stifel | Buy |
| 2018-03-06 | Reiterato | Stifel | Buy |
| 2018-02-15 | Reiterato | SunTrust | Buy |
| 2018-01-23 | Reiterato | Credit Suisse | Outperform |
| 2017-11-15 | Iniziato | SunTrust | Buy |
| 2017-11-09 | Iniziato | Jefferies | Buy |
| 2017-10-11 | Reiterato | RBC Capital Mkts | Outperform |
| 2017-09-15 | Iniziato | RBC Capital Mkts | Outperform |
Mostra tutto
Anaptysbio Inc Borsa (ANAB) Ultime notizie
Charles Schwab Investment Management Inc. Trims Stake in AnaptysBio, Inc. $ANAB - MarketBeat
What machine learning models say about AnaptysBio Inc.Dollar Strength & Free High Accuracy Swing Entry Alerts - Newser
Can swing trading help recover from AnaptysBio Inc. lossesJuly 2025 Catalysts & Safe Capital Investment Plans - Newser
Using Ichimoku Cloud for AnaptysBio Inc. technicalsMarket Trend Report & Free Real-Time Volume Trigger Notifications - Newser
Technical signs of recovery in AnaptysBio Inc.Earnings Growth Summary & Safe Capital Growth Plans - Newser
Will AnaptysBio Inc. price bounce be sustainableJuly 2025 Levels & Real-Time Stock Movement Alerts - Newser
Nuveen LLC Makes New Investment in AnaptysBio, Inc. $ANAB - MarketBeat
AnaptysBio Inc.’s volatility index tracking explainedDollar Strength & Stepwise Entry and Exit Trade Signals - Newser
Can trapped investors hope for a rebound in AnaptysBio Inc.2025 Fundamental Recap & Fast Gain Swing Trade Alerts - Newser
Can AnaptysBio Inc. ride the EV waveMarket Sentiment Review & Real-Time Volume Spike Alerts - khodrobank.com
Chart based analysis of AnaptysBio Inc. trends2025 Bull vs Bear & Verified Entry Point Signals - Newser
Is AnaptysBio Inc. a cyclical or defensive stockJuly 2025 Technicals & Fast Entry and Exit Trade Plans - khodrobank.com
Historical volatility pattern of AnaptysBio Inc. visualizedJuly 2025 Recap & Expert Approved Momentum Trade Ideas - Newser
Will AnaptysBio Inc. continue its uptrendSwing Trade & Free Reliable Trade Execution Plans - Newser
What does recent volatility data suggest for AnaptysBio Inc.Wall Street Watch & Intraday High Probability Alerts - Newser
Will AnaptysBio Inc. benefit from geopolitical trendsWeekly Stock Recap & Verified Swing Trading Watchlists - khodrobank.com
Vanguard Group Inc. Trims Stock Position in AnaptysBio, Inc. $ANAB - MarketBeat
How cyclical is AnaptysBio Inc.’s revenue streamPortfolio Risk Report & Weekly Setup with High ROI Potential - خودرو بانک
Visualizing AnaptysBio Inc. stock with heatmapsJuly 2025 Summary & Trade Opportunity Analysis Reports - Newser
Investment Review: Will AnaptysBio Inc. outperform tech stocksEarnings Growth Summary & AI Driven Stock Reports - khodrobank.com
Downgrade Watch: Will AnaptysBio Inc. outperform its industry peers2025 Volume Leaders & Safe Capital Growth Stock Tips - خودرو بانک
AnaptysBio Inc. stock momentum explainedJuly 2025 Selloffs & Free AI Powered Buy and Sell Recommendations - Newser
Strategies to average down on AnaptysBio Inc.2025 Fundamental Recap & Smart Allocation Stock Tips - Newser
What recovery options are there for AnaptysBio Inc.M&A Rumor & Safe Entry Trade Reports - Newser
Bollinger Bands Expand on AnaptysBio Inc. — Volatility Ahead getLinesFromResByArray error: size == 0 - thegnnews.com
Cresset Asset Management LLC Makes New $272,000 Investment in AnaptysBio, Inc. $ANAB - MarketBeat
Trend analysis for AnaptysBio Inc. this weekJuly 2025 Market Mood & Low Drawdown Investment Strategies - Newser
How to use a screener to detect AnaptysBio Inc. breakoutsTrade Volume Report & Real-Time Volume Trigger Notifications - Newser
Will a bounce in AnaptysBio Inc. offer an exit2025 Earnings Surprises & Verified Entry Point Signals - Newser
Statistical indicators supporting AnaptysBio Inc.’s strength2025 AllTime Highs & High Accuracy Swing Trade Signals - Newser
Earnings visualization tools for AnaptysBio Inc.July 2025 Analyst Calls & Low Risk High Reward Ideas - Newser
Building trade automation scripts for AnaptysBio Inc.2025 Price Targets & Weekly High Return Opportunities - Newser
AnaptysBio Inc. stock trend forecastPortfolio Gains Summary & Breakout Confirmation Alerts - Newser
Will earnings trigger a reversal in AnaptysBio Inc.July 2025 Momentum & Free Expert Approved Momentum Trade Ideas - Newser
Will AnaptysBio Inc. rebound enough to break evenInsider Selling & High Yield Stock Recommendations - Newser
Is AnaptysBio Inc. stock a growth or value playMarket Trend Summary & Daily Stock Trend Reports - Newser
Can machine learning forecast AnaptysBio Inc. recoveryTrade Exit Summary & Entry Point Confirmation Alerts - Newser
What moving averages say about AnaptysBio Inc.July 2025 WrapUp & AI Powered Buy/Sell Recommendations - Newser
Anaptysbio Inc Azioni (ANAB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Anaptysbio Inc Azioni (ANAB) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| RENTON HOLLINGS | Director |
Aug 08 '25 |
Sale |
19.62 |
10,231 |
200,714 |
4,965 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):